BR0007966A - Composições e métodos para o tratamento e a prevenção de infecção bacteriana patogênica com base na função essencial da metilação do dna na virulência bacteriana - Google Patents

Composições e métodos para o tratamento e a prevenção de infecção bacteriana patogênica com base na função essencial da metilação do dna na virulência bacteriana

Info

Publication number
BR0007966A
BR0007966A BR0007966-9A BR0007966A BR0007966A BR 0007966 A BR0007966 A BR 0007966A BR 0007966 A BR0007966 A BR 0007966A BR 0007966 A BR0007966 A BR 0007966A
Authority
BR
Brazil
Prior art keywords
methods
compositions
prevention
treatment
essential function
Prior art date
Application number
BR0007966-9A
Other languages
English (en)
Inventor
Michael Mahan
Douglas M Heithoff
David A Low
Robert L Sinsheimer
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of BR0007966A publication Critical patent/BR0007966A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/107—Vibrio
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: "COMPOSIçõES E MéTODOS PARA O TRATAMENTO E A PREVENçãO DE INFECçãO BACTERIANA PATOGêNICA COM BASE NA FUNçãO ESSENCIAL DA METILAçãO DO DNA NA VIRULêNCIA BACTERIANA". A presente invenção é dirigida para as composições de vacinas contendo bactérias patogênicas, tais como a Salmonella, tendo mutações genéticas não-reversas que alteram a atividade do DNA adenina metilase (Dam), e os métodos usando estas composições para fazer surgir uma resposta imunológica. A invenção também proporciona métodos para a preparação de vacinas, assim como métodos de exame para identificar agentes que possam ter atividade antibacteriana.
BR0007966-9A 1999-02-02 2000-02-02 Composições e métodos para o tratamento e a prevenção de infecção bacteriana patogênica com base na função essencial da metilação do dna na virulência bacteriana BR0007966A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24195199A 1999-02-02 1999-02-02
US30560399A 1999-05-05 1999-05-05
US49561400A 2000-02-01 2000-02-01
PCT/US2000/002866 WO2000045840A1 (en) 1999-02-02 2000-02-02 Compositions and methods for treating and preventing pathogenic bacterial infection based on the essential role of dna methylation in bacterial virulence

Publications (1)

Publication Number Publication Date
BR0007966A true BR0007966A (pt) 2001-11-06

Family

ID=27399537

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0007966-9A BR0007966A (pt) 1999-02-02 2000-02-02 Composições e métodos para o tratamento e a prevenção de infecção bacteriana patogênica com base na função essencial da metilação do dna na virulência bacteriana

Country Status (8)

Country Link
EP (1) EP1150711A1 (pt)
JP (1) JP2002536339A (pt)
AU (1) AU776864B2 (pt)
BR (1) BR0007966A (pt)
CA (1) CA2359469A1 (pt)
MX (1) MXPA01007747A (pt)
NZ (1) NZ512685A (pt)
WO (1) WO2000045840A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7026155B2 (en) 1999-02-02 2006-04-11 Regents Of The University Of California Method of reducing bacterial proliferation
US6602680B2 (en) 2000-07-14 2003-08-05 The Regents Of The University Of California Production of gabaergic cells
GB0029379D0 (en) * 2000-12-01 2001-01-17 Arrow Therapeutics Ltd A method for identifying enzyme inhibitors
ITRM20010295A1 (it) * 2001-05-30 2002-12-02 Stresstech S R L Metodo per ottenere microrganismi patogeni non virulenti attraverso una modificazione dello stato fisico e/o dinamico delle loro membrane bi
JP2003189861A (ja) * 2001-12-25 2003-07-08 Japan Science & Technology Corp 細菌の運動性関連遺伝子群発現の制御
AU2020328511A1 (en) 2019-08-09 2022-03-03 Nutcracker Therapeutics, Inc. Methods and apparatuses for manufacturing for removing material from a therapeutic composition
JPWO2021107013A1 (pt) * 2019-11-29 2021-06-03

Also Published As

Publication number Publication date
MXPA01007747A (es) 2002-07-02
NZ512685A (en) 2003-10-31
AU3222100A (en) 2000-08-25
WO2000045840A1 (en) 2000-08-10
JP2002536339A (ja) 2002-10-29
WO2000045840A8 (en) 2001-03-22
CA2359469A1 (en) 2000-08-10
AU776864B2 (en) 2004-09-23
EP1150711A1 (en) 2001-11-07

Similar Documents

Publication Publication Date Title
BR0113822A (pt) Vacina
Enesco et al. α-Tocopherol increases lifespan in the rotifer Philodina
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
BR9810745A (pt) Derivados de benzimidazol
TW246641B (pt)
PL398576A1 (pl) Preparaty szczepionek, preparaty farmaceutyczne, atenuowany wirus grypy, sposoby szczepienia, sposoby zapobiegania chorobie zakaznej, sposoby leczenia lub profilaktyki nowotworów, kompozycje szczepionek i kompozycje farmaceutyczne
BR0013010A (pt) Formulação de cloreto de sódio de moxifloxacina
BR0314511A (pt) Seleção e uso de bactérias de ácido lático para reduzir a inflamação causada por helicobater
ES2109260T3 (es) Eritrocitos transformados, procedimiento para prepararlos y su utilizacion en composiciones farmaceuticas.
TR200101649T2 (tr) Piperazin türevleri.
CY1108178T1 (el) Βακτηριο που προκαλει νοσο των πουλερικων και εμβολιο προερχομενο εξ' αυτου
BR0006291A (pt) Bactéria do gênero salmonella, vacina para aproteção de animais contra a salmonelose, uso deuma bactéria, e, processo para a preparação deuma vacina
BR0007966A (pt) Composições e métodos para o tratamento e a prevenção de infecção bacteriana patogênica com base na função essencial da metilação do dna na virulência bacteriana
TR200001948T2 (tr) Mikobakteri vaccaesinden türetilen kompozisyonlar ve bunların kullanımları için metotlar.
DE69521275D1 (de) Pharmazeutische Zubereitungen enthaltend Cefaclor
MX9805441A (es) Compuestos terapeuticos.
ES2098788T3 (es) Nueva bacteria que provoca enfermedades en las aves y vacuna derivada de esta bacteria.
BR0109928A (pt) Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal
BR0012973B1 (pt) Uso de bactéria do ácido láctico pertencente ao gênero Bifidobacterium, e composição alimentícia ou farmacêutica.
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
ITMI913493A0 (it) Dispositivo per la disinfezione o la immunizzazione di zone del corpo umano esposte al contagio, da germi, batteri e virus
HUP0003845A2 (hu) Antimikrobiális 8a-azalidok alkalmazása
ATE49101T1 (de) Zusammensetzungen zur desinfektion und zur sterilisation.
MX9709347A (es) Micoplasma synoviae no virulento y vacuna del mismo.
ECSP003786A (es) Gama-hidroxil-2 (fluoroalquiloaminocarbonil)-1-piperacinapentanamidas y usos de ellas

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 8A E 9A ANUIDADES

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 NA RPI2003 DE 26/05/2009.